Abstract

Currently, vaccination is the main measure to combat rabies in domestic and wild animals. Inactivated and live vaccines are used for this purpose. Oral vaccines for wild carnivores contain live attenuated rabies viruses in liquid or freeze-dried form, which are packaged inside edible baits. Since there are no consistent data showing advantages of liquid and freeze-dried oral products for vaccine-induced immunity against rabies in animals, we compared effectiveness of these rabies vaccines produced from rabies virus strain VRC-RZ2. Immunogenicity was tested in mongrel dogs aged 3 months and older that are seronegative for rabies virus antigens. The animals were randomly divided into three groups: two experimental and one control group. Group One was fed a block-type bait containing a blister with liquid virus-containing suspension, Group Two was given a block-type bait containing a gelatin capsule with freeze-dried virus suspension. On Day 21 post vaccination, blood samples were taken from all the animals and the obtained sera were examined in virus neutralization test to measure virus neutralizing antibodies titers. The level of the immune response against rabies in the vaccinated dogs was assessed by intracerebral infection of animals with virulent rabies virus strain CVS. The carried out research demonstrated that both groups of the vaccinated dogs had approximately the same titers of virus neutralizing antibodies that ranged from 3.25 to 4.33 log 2 . The virus neutralizing antibodies observed in the immunized dogs ensured good protection from virulent CVS strain. All animals of the control group died after infection demonstrating clinical signs of paralytic rabies. The results obtained show that both forms of the oral rabies vaccines are effective.

Highlights

  • Oral vaccines for wild carnivores contain live attenuated rabies viruses in liquid or freeze-dried form, which are packaged inside edible baits

  • Since there are no consistent data showing advantages of liquid and freeze-dried oral products for vaccine-induced immunity against rabies in animals, we compared effectiveness of these rabies vaccines produced from rabies virus strain VRC-RZ2

  • Immunogenicity was tested in mongrel dogs aged 3 months and older that are seronegative for rabies virus antigens

Read more

Summary

МАТЕРИАЛЫ И МЕТОДЫ

Данный штамм рекомендован для изготовления вакцины против бешенства, предназначенной для оральной иммунизации животных (патент РК No 174532). – жидкой – препарат массой 25−30 г содержит 10 см суспензии вируса бешенства в блистерной упаковке, заключенной в брикет-приманку. – лиофилизированной – препарат массой 25−30 г содержит 10 см лиофилизированной суспензии вируса бешенства со стабилизирующим и кислотоустойчивым полимером в желатиновой капсуле, заключенной в брикет-приманку. В эксперименте использовали референс-штамм CVS вируса бешенства, который поддерживается и сохраняется в коллекции микроорганизмов РГП «НИИПББ» (Казахстан). Через 21 сут после вакцинации у всех собак отбирали пробы крови, полученные сыворотки исследовали в РН [23] для определения титров вируснейтрализующих антител (ВНА). С целью оценки антирабического иммунитета через 21 сут после вакцинации животных всех групп заражали интрацеребрально штаммом CVS вирулентного вируса бешенства в дозе 100 и 1000 MЛД50 и проводили клиническое наблюдение в течение 21 сут. Fig. Effectiveness of oral vaccination of dogs with liquid and freeze-dried vaccines

РЕЗУЛЬТАТЫ И ОБСУЖДЕНИЕ
СПИСОК ЛИТЕРАТУРЫ
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call